Association of IDH1 mutations with survival and recurrence in resected intrahepatic cholangiocarcinoma received or not received adjuvant chemotherapy. [PDF]
Wang P +12 more
europepmc +1 more source
Research progress on immune checkpoint inhibitors in intrahepatic cholangiocarcinoma. [PDF]
Yin Z, Zhang L, Li J, Tan H, Ma B.
europepmc +1 more source
Perioperative and precision strategies in resectable intrahepatic cholangiocarcinoma. [PDF]
Chen L, Han R, Song T, Song P, Tang W.
europepmc +1 more source
CT-derived Body Composition Radiomics to Predict Early Recurrence in Intrahepatic Cholangiocarcinoma. [PDF]
Singh Y.
europepmc +1 more source
Mutant Isocitrate Dehydrogenase 1 Sensitizes Intrahepatic Cholangiocarcinoma Cells to MDM2 Inhibitors. [PDF]
Liu CT +8 more
europepmc +1 more source
Artificial intelligence and radiomics on computed tomography for differentiating hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a multimodal integration approach. [PDF]
Pan C +7 more
europepmc +1 more source
Hepatic Artery Infusion Pump Therapy for Intrahepatic Cholangiocarcinoma: Indications and Outcomes. [PDF]
Ho J, Xiao S, Hernandez JM.
europepmc +1 more source
Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic target. [PDF]
Werner T +17 more
europepmc +1 more source
Preoperative Prognostic Score for Patients with Intrahepatic Cholangiocarcinoma Undergoing Curative-Intent Resection. [PDF]
Chindaprasirt J +11 more
europepmc +1 more source
Intrahepatic Cholangiocarcinoma Masquerading as Liver Abscess: A Case Report With Multimodal Imaging. [PDF]
Song C, Xu Y, Zhang Y, Miao R.
europepmc +1 more source

